Literature DB >> 8969318

Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?

B O'Brien1.   

Abstract

Mesh:

Year:  1996        PMID: 8969318

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  32 in total

1.  Economic evaluation and clinical trials: size matters.

Authors:  A Briggs
Journal:  BMJ       Date:  2000-12-02

2.  Randomized controlled trial and economic evaluation.

Authors:  S Jain; N K Arora
Journal:  Indian J Pediatr       Date:  2000-05       Impact factor: 1.967

Review 3.  Design, analysis and presentation of multinational economic studies: the need for guidance.

Authors:  Francis Pang
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 4.  Testing the validity of cost-effectiveness models.

Authors:  C McCabe; S Dixon
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

5.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  J Soto
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

6.  Economic evaluation of antibacterials in the treatment of acute sinusitis.

Authors:  C Laurier; J Lachaine; M Ducharme
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

7.  The problem of protocol driven costs in pharmacoeconomic analysis.

Authors:  D Coyle; K M Lee
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

Review 8.  Reassessing the relevance of pharmacoeconomic analyses in formulary decisions.

Authors:  J A Johnson; E Friesen
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

9.  A decision chart for assessing and improving the transferability of economic evaluation results between countries.

Authors:  Robert Welte; Talitha Feenstra; Hans Jager; Reiner Leidl
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Transparency in economic evaluations.

Authors:  Suzanne Hill
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.